Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Name: Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Published: 2007
License: Public Domain

Novartis Pharmaceuticals · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

leukemia

myelogenous leukemia, leukemia, bone marrow, leukemia symptoms, cml, complete blood count, lymphocyte, blood cancer, leukocytes, chronic leukemia, bone marrow biopsy, leukemia research

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 831782
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.